Dupilumab in improving control of severe asthma in real life. Report of two cases

被引：0
|
作者：
Leru, P. [1 ]
Anton, V. [2 ]
机构：
[1] Carol Davila Univ Med & Pharm, Bucharest, Romania
[2] Colentina Clin Hosp, Bucharest, Romania
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000946
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of Dupilumab in a Patient With Severe Asthma Complicated With Recurrent Anaphylaxis: A Case Report
    Otani, T.
    Iwamoto, H.
    Horimasu, Y.
    Yamaguchi, K.
    Sakamoto, S.
    Masuda, T.
    Miyamoto, S.
    Nakashima, T.
    Fujitaka, K.
    Hamada, H.
    Hattori, N.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 230 - 232
  • [22] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
    de Llano, Luis A. Perez
    Cosio, Borja G.
    Astiarraga, Ignacio Lobato
    Campos, Gregorio Soto
    Alonso, Miguel Angel Tejedor
    Malanda, Nuria Marina
    Galo, Alicia Padilla
    Landa, Isabel Urrutia
    de la Rosa, Francisco J. Michel
    Garcia-Moguel, Ismael
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 79 - 88
  • [23] Asthma control test in real life
    Ciprandi, Giorgio
    Gallo, Fabio
    Ricciardolo, Fabio L. M.
    JOURNAL OF ASTHMA, 2017, 54 (02) : 114 - +
  • [24] Tezepelumab-ekko Improved Asthma Control and Asthma Symptom in Adults with Uncontrolled and Severe Asthma in Real-Life
    Gupta, Misha
    Singh, Harjinder
    Diaz, Joseph
    Kaur, Shubhkarman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB21 - AB21
  • [25] Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study
    Quarato, Carla Maria Irene
    Tondo, Pasquale
    Lacedonia, Donato
    Soccio, Piera
    Fuso, Paolo
    Sabato, Eugenio
    Hoxhallari, Anela
    Foschino Barbaro, Maria Pia
    Scioscia, Giulia
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [26] Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study
    Busse, W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [27] Dupilumab Shows Sustained Efficacy and Improvements in Asthma Control and Health-Related Quality of Life in Patients with Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, M.
    Ford, L. B.
    Maspero, J. F.
    Pavord, I. D.
    Langton, D.
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Amin, N.
    Hardin, M. E.
    Zhang, Y.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
    Elio Novembre
    Mattia Giovannini
    Simona Barni
    Francesca Mori
    Italian Journal of Pediatrics, 48
  • [29] From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
    Novembre, Elio
    Giovannini, Mattia
    Barni, Simona
    Mori, Francesca
    ITALIAN JOURNAL OF PEDIATRICS, 2022, 48 (01)
  • [30] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
12345